Your browser doesn't support javascript.
loading
Divergent synthesis of thapsigargin analogs.
Chu, Hang; Dünstl, Georg; Felding, Jakob; Baran, Phil S.
Afiliación
  • Chu H; Department of Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, United States.
  • Dünstl G; Research & Development, LEO Pharma, A/S Industriparken 55, 2750 Ballerup, Denmark.
  • Felding J; Research & Development, LEO Pharma, A/S Industriparken 55, 2750 Ballerup, Denmark.
  • Baran PS; Department of Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, United States. Electronic address: pbaran@scripps.edu.
Bioorg Med Chem Lett ; 28(16): 2705-2707, 2018 09 01.
Article en En | MEDLINE | ID: mdl-29636219
Thapsigargin (3) is a potent inhibitor of the SERCA-pump protein, with potential for application in a variety of medicinal areas. The efficient and scalable syntheses of thapsigargin (3) and nortrilobolide (2) have been disclosed previously. To demonstrate the modularity of the previous routes, three natural products (compounds 6, 13, 15) and four analogs (compounds 17-20) have been divergently prepared from a common building block featuring varied acyl chains at the C2, C3, and C8 positions. Biological tests revealed that all of the compounds prepared displayed promising activity profiles.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Tapsigargina / Inhibidores Enzimáticos / ATPasas Transportadoras de Calcio del Retículo Sarcoplásmico Idioma: En Revista: Bioorg Med Chem Lett Asunto de la revista: BIOQUIMICA / QUIMICA Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Tapsigargina / Inhibidores Enzimáticos / ATPasas Transportadoras de Calcio del Retículo Sarcoplásmico Idioma: En Revista: Bioorg Med Chem Lett Asunto de la revista: BIOQUIMICA / QUIMICA Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos